In this study, we find a synergistic inhibitory effect of co-targeting CD73 and immune checkpoints in pancreatic cancer and demonstrate the significant role of tumor cell-autonomous CD73 and tumor cell-autocrine adenosine–Adora2a signaling in stimulating CCL5 transcription and Treg recruitment. This evidence concerns the gene NT5E and neoplasm.